Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
A specific percentage figure for retatrutide is not currently something we can verify
PeerJ 4, e2584
Recently, the newly developed drug tirzepatide, which targets both the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, was introduced to the market to treat type 2 diabetes and obesity in 2022 and 2023, respectively (Table 1)
Because of these potential side effects, people with diabetes (PWD) should consider how this could affect blood sugar management
US$ 21.77
US$ 28.25
US$ 29.08
US$ 28.05
US$ 25.04
US$ 26.87
US$ 29.63
